Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Plexxikon is a leader in the discovery and development of novel small molecule pharmaceuticals to treat human disease. Plexxikon’s proprietary Scaffold-Based Drug Discovery platform is being applied to build therapeutic franchises in metabolic and cardiovascular disease, inflammation and oncology. This discovery process integrates a number of state-of-the-art technologies, including structural screening as one key component that provides a significant competitive advantage over other drug discovery approaches. To date, the company has discovered a portfolio of clinical and preclinical stage compounds in each of these franchises. Currently, the company’s most advanced program is a PPAR pan-agonist for the treatment of diabetes and related cardiovascular ( www.plexxikon.com )
Plexxikon Inc.
91 Bolivar Drive
Berkeley, California 94710
USA
Tel: (510) 647-4000
Fax: (510) 548-8014